What actually happens to your weight and health when you stop GLP-1 drugs?
The short answer is that the weight comes back, and the health improvements fade. The strongest evidence comes from a 2026 systematic review and meta-analysis of 37 studies involving over 9,300 participants, which found that after stopping weight management medications (including GLP-1 drugs), people regained weight at an average rate of 0.3 to 0.4 kg (about 0.7 to 0.9 pounds) per month [1]. That means if you lost 10 kg (22 lbs) on the drug, you could regain roughly half of it within a year if you do nothing else.
Even more concerning, the same review projected that all the cardiometabolic benefits — improvements in blood pressure, cholesterol, and blood sugar — would return to their pre-treatment levels within 1.4 years after stopping the medication [1]. So the health gains are not lasting; they are tied to continued drug use.
This pattern is not unique to GLP-1 drugs. A 2026 review on GLP-1 receptor agonists specifically notes that weight regain after discontinuation is 'substantial' and follows a characteristic pattern, with a large proportion of the regain happening in the early months after stopping [2]. This front-loaded regain means the first few months are a critical window where the biological drive to eat increases sharply as the drug's appetite-suppressing effects wear off.
Is there any way to keep the weight off after stopping GLP-1 drugs?
Yes, there are strategies that may help, but they require active effort — the benefits do not persist on their own. One promising approach is to switch to a lower-dose maintenance regimen rather than stopping abruptly. A 2026 study found that people who took a daily oral GLP-1 pill (orforglipron) after stopping injectable GLP-1 drugs were able to maintain 75-79% of their earlier weight loss [3]. However, this was a small study (376 participants), and it still required continued medication — just at a lower intensity.
Another approach is to combine medication with lifestyle changes. The 2026 meta-analysis found that weight regain after GLP-1 drugs was faster than after behavioral weight management programs (by about 0.3 kg per month) [1]. This suggests that if you build strong diet and exercise habits while on the drug, you might slow the regain, but the evidence is clear: stopping the drug without a plan leads to rapid weight gain.
Dietary fiber may also play a supporting role. A 2026 review discusses how fiber can stimulate the body's own GLP-1 production through gut fermentation, potentially helping to stabilize appetite and weight after drug withdrawal [5]. But fiber alone produces more modest weight loss than GLP-1 drugs, so it is best thought of as a foundation, not a replacement.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2025 to 2026, 5 from 2024 or later, 4 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 46 papers retrieved from a database of over 500 million.
Sources used in this answer
Weight regain after cessation of medication for weight management: systematic review and meta-analysis
In a systematic review and meta-analysis of 37 studies (9,341 participants), weight regain after stopping weight management medications averaged 0.3-0.4 kg per month, and all cardiometabolic benefits were projected to return to baseline within 1.4 years; regain was faster than after behavioral programs.
Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.
A 2026 review confirms that GLP-1 discontinuation leads to substantial weight regain, with a front-loaded pattern in the early months, driven by restored appetite and hormonal changes; reduced-intensity maintenance may attenuate regain.
GLP-1: Daily pill reduces weight rebound after stopping injections, study suggests.
A small study (376 participants) found that switching to a daily oral GLP-1 pill (orforglipron) after stopping injectable GLP-1 drugs helped maintain 75-79% of prior weight loss.
Great Debates: Undergoing the Knife versus Pill-Popping—The Comparative Efficacy and Cost-Effectiveness of Bariatric Surgery and GLP-1 Receptor Agonists in the Management of Obesity
A 2025 review notes that GLP-1 RAs require sustained adherence, and weight regain is common upon discontinuation; bariatric surgery offers superior long-term weight loss (10-year rates of 23-27% total weight loss).
Dietary fiber and GLP-1 receptor agonists in obesity management: converging mechanisms, interactions, and strategies for durable weight control.
A 2026 review discusses that dietary fiber can stimulate endogenous GLP-1 production and may help stabilize weight after drug withdrawal, but fiber alone produces more modest weight loss than GLP-1 RAs.